Peter Marks
Director of the Center for Biologics Evaluation and Research at the FDA
Meet Peter Marks
During his wide-ranging career, Peter Marks has been involved in practicing internal medicine and clinical science with Brigham and Women's Hospital in Boston, academic medicine at Yale (where he led the adult leukemia service), pharmaceutical drug development, and most recently, regulation. As head director of CBER, Peter plays a pivotal role in the development and commercialization of advanced medicines in the US.